Cargando…
Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861182/ https://www.ncbi.nlm.nih.gov/pubmed/35202794 http://dx.doi.org/10.1016/j.annonc.2022.02.006 |
| _version_ | 1784654833284808704 |
|---|---|
| author | Di Noia, V. Pimpinelli, F. Renna, D. Maccallini, M.T. Gariazzo, L. Riva, F. Sperandio, E. Giannarelli, D. Cognetti, F. |
| author_facet | Di Noia, V. Pimpinelli, F. Renna, D. Maccallini, M.T. Gariazzo, L. Riva, F. Sperandio, E. Giannarelli, D. Cognetti, F. |
| author_sort | Di Noia, V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8861182 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88611822022-02-22 Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer Di Noia, V. Pimpinelli, F. Renna, D. Maccallini, M.T. Gariazzo, L. Riva, F. Sperandio, E. Giannarelli, D. Cognetti, F. Ann Oncol Letter to the Editor European Society for Medical Oncology. Published by Elsevier Ltd. 2022-05 2022-02-22 /pmc/articles/PMC8861182/ /pubmed/35202794 http://dx.doi.org/10.1016/j.annonc.2022.02.006 Text en © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Di Noia, V. Pimpinelli, F. Renna, D. Maccallini, M.T. Gariazzo, L. Riva, F. Sperandio, E. Giannarelli, D. Cognetti, F. Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer |
| title | Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer |
| title_full | Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer |
| title_fullStr | Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer |
| title_full_unstemmed | Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer |
| title_short | Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer |
| title_sort | potentiation of humoral response to the bnt162b2 vaccine after the third dose in patients with solid cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861182/ https://www.ncbi.nlm.nih.gov/pubmed/35202794 http://dx.doi.org/10.1016/j.annonc.2022.02.006 |
| work_keys_str_mv | AT dinoiav potentiationofhumoralresponsetothebnt162b2vaccineafterthethirddoseinpatientswithsolidcancer AT pimpinellif potentiationofhumoralresponsetothebnt162b2vaccineafterthethirddoseinpatientswithsolidcancer AT rennad potentiationofhumoralresponsetothebnt162b2vaccineafterthethirddoseinpatientswithsolidcancer AT maccallinimt potentiationofhumoralresponsetothebnt162b2vaccineafterthethirddoseinpatientswithsolidcancer AT gariazzol potentiationofhumoralresponsetothebnt162b2vaccineafterthethirddoseinpatientswithsolidcancer AT rivaf potentiationofhumoralresponsetothebnt162b2vaccineafterthethirddoseinpatientswithsolidcancer AT sperandioe potentiationofhumoralresponsetothebnt162b2vaccineafterthethirddoseinpatientswithsolidcancer AT giannarellid potentiationofhumoralresponsetothebnt162b2vaccineafterthethirddoseinpatientswithsolidcancer AT cognettif potentiationofhumoralresponsetothebnt162b2vaccineafterthethirddoseinpatientswithsolidcancer |